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ABSTRACT
Introduction: The Groningen Effort Test (GET) is a recently developed performance validity test
(PVT) for the identification of noncredible performance in a neuropsychological assessment of
attention abilities. Because the majority of already established PVTs are based on memory func-
tions, the GET has the potential to make a valuable contribution to validity testing.
Method: The current study examined the utility of the GET in the detection of feigned cognitive
dysfunction after acquired brain injury (ABI) and its incremental validity over already established
PVTs, namely the Test of Memory Malingering (TOMM), the Dot Counting Test (DCT), and the
b Test. Three hundred and forty-eight participants took part in this study, including 58 patients
with ABI (stroke or traumatic brain injury), 43 healthy individuals instructed to show normal
behavior, and 247 healthy individuals instructed to feign cognitive dysfunction after ABI.
Results: With excellent overall classification accuracy, the GET performed close to the level of the
TOMM, and superior to the b Test and DCT. Data analyses further revealed that the GET provides
additional diagnostic accuracy compared to the b Test and the DCT in the detection of feigned
cognitive dysfunction, but has no incremental validity over the TOMM. For each of the four PVTs in
this study, diagnostic sensitivity was independent of the simulation strategy used.
Conclusions: It is concluded that the GET is an attention-based PVT with promising test characteristics
and high diagnostic accuracy in the detection of noncredible cognitive performance using a simulation
design. Given the results can be replicated in studies using known-groups methodology, it may be
a useful tool for clinical practice to complement neuropsychological assessments of patients with ABI.
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Patients with acquired brain injury (ABI; such as traumatic
brain injury or stroke) frequently suffer from a range of
cognitive dysfunctions, including difficulties in attention,
concentration, memory, perception, and action planning
(Jennekens, de Casterlé, & Dobbels, 2010; Sun, Tan, & Yu,
2014). Routine clinical practice therefore often includes
a comprehensive neuropsychological assessment of cogni-
tive functions in patients with ABI, in order to objectively
measure the cognitive impairments reported by patients,
characterize cognitive strengths and weaknesses, and guide
treatment planning (Lezak, 2004). In this context, position
papers and consensus reports state that validity testing
should be an integral part of any routine neuropsychologi-
cal assessment (Bush et al., 2005; Heilbronner, Sweet,
Morgan, Larrabee,&Millis, 2009; Larrabee, 2007), allowing
the clinician to make conclusions about both the integrity
of function and credibility of demonstrated symptoms
during assessment.
Estimates regarding the prevalence of feigned or exag-
gerated cognitive dysfunction are difficult to derive and
depend onmany factors, including the context, the sample
studied, and the instruments used to identify feigned or
exaggerated cognitive dysfunction (Dandachi-FitzGerald,
Ponds, &Merten, 2013; Greiffenstein, Baker, & Gola, 1994;
Mittenberg, Patton, Canyock, & Condit, 2002). However,
there is broad consensus on the importance of the detec-
tion of noncredible symptom reporting and performance
in an early phase of clinical care on the basis of instruments
designed and validated for this purpose (Bush et al., 2005;
Haines & Norris, 2001; Heilbronner et al., 2009).
Various performance validity tests (PVTs) have been
introduced, with a considerable number of themost widely
used PVTs being memory-based, such as the Test of
Memory Malingering (TOMM; Tombaugh, 1996), the
Word Memory Test (WMT; Green, Allen, & Astner,
1996), the Medical Symptom Validity Test (MSVT;
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Green, 2005a), and the Nonverbal Medical Symptom
Validity Test (NV-MSVT; Green, 2005b). Other estab-
lished PVTs are based on different principles, such as
visual perception (e.g., Dot Counting Test; DCT; Boone,
Lu, & Herzberg, 2002a), or letter recognition and discri-
mination (e.g., b Test; Boone, Lu, & Herzberg, 2002b).
While the psychometric properties of these PVTs have
been frequently studied (Binks, Gouvier, & Waters, 1997;
Rees, Tombaugh, Gansler, & Moczynski, 1998), and while
these tests are certainly useful for clinical practice to detect
feigned memory deficits, they might be limited in their
accuracy to detect individuals feigning attention deficits,
such as distraction, lapses of attention, mind wandering, or
problems with sustaining attention. The importance of
assessing noncredible attention performance is underlined
by qualitative research on the commonly applied deception
strategies, which have identified, next to memory loss
(76%), slow response time (32%), poor concentration
(12%), and confusion (16%) as the most common strate-
gies (Tan, Slick, Strauss, & Hultsch, 2002). Because simu-
lated attention deficits, as constituted by slow response
time and poor concentration, make up to 44% of the
most commonly used simulation strategies (Tan et al.,
2002), it can be concluded that there is a need for validity
tests that are specifically based on attention performance.
The Groningen Effort Test (GET; Fuermaier, Tucha,
Koerts, Aschenbrenner, & Tucha, 2017; Fuermaier et al.,
2016) is an attention-based PVT that has been recently
developed to detect the noncredible attention perfor-
mance of individuals during psychiatric evaluation. In
the context of adult attention-deficit/hyperactivity dis-
order (ADHD) using a simulation design, the GET
shows excellent diagnostic accuracy in the detection of
feigned attention deficits, with 88% sensitivity toward
feigned ADHD and 90% specificity toward genuine
ADHD. Nevertheless, to date, little is known about the
GET’s utility to differentiate between credible and non-
credible cognitive test performance among patients
with ABI.
The present study aims to address this issue and
examines the utility of the GET in the detection of the
noncredible cognitive performance of patients after
ABI. This study further aims to determine whether
individuals applying different simulation strategies can
be better identified with the GET rather than already
established PVTs. These objectives are addressed in
a study employing a simulation design with five groups:
healthy individuals allocated to either a healthy control
group required to perform all tests to the best of their
abilities, or to one of four simulation groups asked to
perform the measures as if they suffered from cognitive
dysfunction following ABI. The PVT performances of
these groups are compared to the performance of
a group of patients with stroke or TBI with genuine
cognitive dysfunctions. We expected the GET to be at
least as useful as other PVTs in the detection of feigned
cognitive dysfunction after ABI. We further expected
the GET to have incremental validity over at least some
of the already established PVTs. Finally, we expected the




Power issues are usually not amajor concern in this type of
research, as relatively large effects are required for the
detection of feigning, which are revealed with relatively
small samples. Rogers (2008), for example, introduced the
classification of effects into moderate if Cohen’s d ≥ .75,
and large if Cohen’s d ≥ 1.25. Based on a group compar-
ison with a two-tailed test and α = .05, revealing
a moderate effect (d = .75) with a desired power (1−β) of
.85 requires a sample size of 33 participants per group,
while a large effect (d = 1.25) requires a sample size of only
13 participants per group. However, a reliable estimation
of classification accuracy requires both a sufficient number
of individuals feigning cognitive dysfunction (to determine
sensitivity), and a sufficient number of patients with gen-
uine cognitive dysfunctions (to determine specificity). We
therefore aimed to exceed the minimum number of parti-
cipants as indicated in the power analysis; attempting to
reach a group size of at least 50 patients with ABI with
genuine cognitive dysfunctions.
Three hundred and forty-eight participants took part in
this prospective study. Patients with ABI (PABI; n = 58)
consisted of patients with TBI (n = 28) or stroke (n = 30),
and were recruited and assessed at two neurological
rehabilitation hospitals in Germany. Healthy individuals
(n = 292) included both controls (CG; n = 43) and
instructed simulators (SIM; n = 247), and were recruited
and assessed by trained graduate students.
Patients with acquired brain injury
All patients with ABI were invited to take part in the study
on a voluntary basis and were not rewarded for their
participation. Patients with ABI included 23 female and
35male participants ranging from17 to 77 years (M±SD=
42.1 ± 16.1). The duration of illness varied between one and
77 months (M ± SD = 8.5 ± 14.4). At the time of assess-
ment, most patients with ABI were on sick leave (n = 43),
others were employed (n = 7), retired (n = 4), in training
(n = 2), or unemployed (n = 2). Neuroimaging support of
the brain injury was provided for 47 patients. Forty-two
patients were on medication at the time of the assessment
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(i.e., antidepressants/stimulants, analgesics, or beta
blockers). The degree of severity for TBI was
assessed using the Glasgow Coma Scale (GCS) and
varied between a minor (n = 2), moderate (n = 2),
and severe (n = 18) degree of severity. A GCS score
was not assessed for six patients with TBI. Patients
with stroke either had an ischemic (n = 22) or
hemorrhagic (n = 8) stroke with the lesion affecting
the left (n = 14), right (n = 12), or both (n = 1)
hemispheres (unknown in n = 3). Rehabilitation
phases ranged from A (acute treatment) to
F (activating long-term care), with the majority of
patients being in rehabilitation phase D (n = 50) at the
time of assessment. In this phase, patients have success-
fully completed early mobilization training and are no
longer dependent on essential nursing care. One patient
was in rehabilitation phase C, meaning that the patient
could actively participate in therapy, but was still depen-
dent on curative medicine and nursing care. Three
patients were in rehabilitation phase E, which focuses
on domestic and vocational rehabilitation. The rehabili-
tation phase was not provided for four patients.
Eight patients with ABI had to be excluded due to one
of the following reasons. Six Patients with ABI failed to
show credibility on the TOMM (n = 1) or DCT (n = 4) as
measures of performance validity, or did not complete
any of the two (n = 1), and two patients with ABI did not
perform the GET (see material section for a description
of the validity measures). Table 1 presents the character-
istics of 50 patients with ABI that were retained in the
present study, including the frequency of patients hav-
ing cognitive impairments (percentile ≤ 10) as indicated
by test norms of standard measures of cognition (see
material section for a description of measures). Between
almost 20% and 50% of patients with TBI performed in
the impaired range on each test of cognition. With
regard to patients post-stroke, the range regarding the
proportion of individuals with particular impairments
was 15% (alertness) and 64% (reaction time in selective
attention; see Table 1).
Healthy individuals
Instructed simulators andnon-simulatinghealthy controlswere
recruited from a first-year psychology program and were
awarded course credit in exchange for participation. Healthy
individuals also had the chance of winning a tablet PC by
participating in the research. The instructed simulation group
included 247 students. Students’ ages ranged from 17 to 34
years (M ± SD = 20.4 ± 2.3) and included 146 female and 101
male participants. Instructed simulators were randomly
assigned to one of the four conditions: (1) naïve TBI simulation
group (NSTBI): n = 66; age (M± SD) = 21.1 ± 2.9 years, gender
Table 1. Characteristics of patients with acquired brain injury.
TBI Stroke Total
Descriptives
N 23 27 50
Age (in years) 36.5 ± 15.5 47.6 ± 15.0 42.5 ± 16.1
Gender (female/male) 6/17 14/13 20/30
Education (in years) 14.0 ± 3.9 13.9 ± 3.6 13.9 ± 3.6
Employment status (unemployed/in training/working/on sick
leave/retired)
2/2/2/15/2 0/0/4/21/2 2/2/6/36/4
IQ (vocabulary skills)a 96.4 ± 9.0 108.5 ± 14.8 103.3 ± 14.0
Neuroimagingb 20 27 47
Medicationc (yes/no) 16/7 23/4 39/11
TBI severityd (minor/moderate/severe) 2/1/14 - -
Stroke type (hemorrhagic/ischemic) - 6/21 -
Strokee Hemisphere (right/left/both) - 11/12/1 -
Duration of illness in months 12.5 ± 15.7 2.6 ± 2.6 7.5 ± 12.1
Rehabilitation phase (C/D/E)f 1/17/2 0/25/1 1/42/3
Cognitive functioning % percentile ≤ 10 % percentile ≤ 10
Visuoconstructive abilitiesg 34.4 ± 18.6 28.6 26.0 ± 16.0 18.5 29.7 ± 17.6
Alertness RTh 367.8 ± 373.7 34.8 259.1 ± 61.4 15.4 310.1 ± 262.7
Selective Attention RTi 624 ± 269 42.9 683 ± 259 63.6 655 ± 263
Selective Attention Omj 8.3 ± 6.8 19.0 6.4 ± 7.8 17.4 7.3 ± 7.3
Divided Attention Omk 3.8 ± 5.0 40.9 2.1 ± 2.1 25.0 2.9 ± 3.9
Word Fluencyl 16.2 ± 6.1 47.4 17.6 ± 7.4 33.3 17.0 ± 6.8
aMultiple Choice Vocabulary Test (MWT-B);
bBrain damage was supported by neuroimaging;
cNumber of patients known to be taking medication at the time of the assessment: Antidepressants, stimulants, analgesics, beta blockers;
dGlasgow Coma Scale (GCS) severity classification for patients with TBI;
eSide of the lesion;
fGerman classification of rehabilitation phases after ABI;
gBlock design of the WAIS-IV;
hTAP phasic Alertness reaction time in milliseconds;
iTAP Visual Scanning reaction time in seconds;
jTAP Visual Scanning Omissions;
kTAP Divided Attention Omission;
lRegensburg Word Fluency Test (S-words). Stroke = All patients with Stroke; TBI = All patients with TBI; Total = All Patients with ABI.
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(female/male) = 40/26; (2) coached TBI simulation group
(CSTBI): n = 64; age (M ± SD) = 20.5 ± 2.3 years, gender
(female/male) = 38/26; (3) naïve stroke simulation group
(NSStroke) n = 58, age (M ± SD) = 20.0 ± 1.9 years, gender
(female/male) = 35/23; and (4) coached stroke simulation
group (CSStroke): n = 59; age (M ± SD) = 19.8 ± 1.7 years,
gender (female/male) = 33/26.
Fifty-five healthy simulating individuals were
excluded for one or more of the following reasons: 26
failed to score higher than six in the Reliable Digit Span,
which served as an indicator of suboptimal effort
(Greiffenstein et al., 1994; see material section for
a description of all measures), 25 reported after the
assessment that they had not put in their best effort to
simulate cognitive dysfunction (cutoff < 3), and 8 parti-
cipants reported having a psychiatric illness.
The non-simulating healthy control group (n = 43)
included 29 females and 14 males ranging from 17 to 25
years (M ± SD = 20.0 ± 1.7). Healthy individuals were
required to perform and pass three different validity tests
(i.e., TOMM, DCT, b Test). Three participants in the
control group failed the b Test (Boone et al., 2002b) and
were therefore excluded. Table 2 provides characteristics
of all participants that were retained in the present study.
Materials
Participants were presented with a comprehensive test
battery that included an inventory of descriptive and
clinical information, tests for cognition and intellectual
functions, several validity tests, and a self-rating of their
own performance. Tests were administered verbally, in
paper and pencil form, or computerized.
Descriptive and clinical information
All participants were asked about descriptive and clin-
ical information including age, gender, highest level of
education, total years of education, current state of
employment (i.e., student, unemployed, in training,
employed, on sick leave, retired), psychiatric conditions,
and medication use. Additional information was
acquired from patients with ABI regarding their
acquired brain injury, including type of brain injury,
duration and severity of injury, whether the brain injury
was supported by neuroimaging data, and the rehabili-
tation phase.
Intellectual functions (vocabulary skills)
Intellectual functions (IQ) were measured using the
Multiple Choice Vocabulary Test(MWT-B; Lehrl, 1995;
Lehrl et al., 1995). The MWT-B has been shown to
provide a valid measure for premorbid IQ that is rela-
tively insensitive to ABI (Crawford, Parker, & Besson,
1988; Suslow, 2009).
Routine measures of cognition (only presented to
patients with ABI)
The subtest Block Design from the Wechsler Adult
Intelligence Scale (WAIS-IV; Petermann, 2012) was used
to assess visuoconstructive abilities and perceptual logic.
Alertness, selective attention, and divided attention were
assessed with subtests from the computerized test battery
for attention performance (TAP; Zimmermann & Fimm,
2010), i.e., Alertness, Visual Scanning, and Divided
Attention. The Regensburg Word Fluency Test (RWT;
Aschenbrenner, Tucha, & Lange, 2000) was used to assess
phonemic word fluency.
Performance validity tests
The Reliable Digit Span (RDS; Greiffenstein et al., 1994)
is an embedded performance validity measure based on
the Digit Span Test of the Wechsler Adult Intelligence
Scale (WAIS-IV; Petermann, 2012). An RDS score
below the cutoff of seven indicates malingered neuro-
cognitive functions or suboptimal effort (Greve et al.,
2007; Heinly, Greve, Bianchini, Love, & Brennan, 2005).
The Groningen Effort Test (GET; Fuermaier et al., 2016,
2017) is an attention-based validity test. In the clinical
evaluation of adults with ADHD, a GET index ≥ −.25
indicates noncredible performance (GET-ADHD index).
The Test ofMemoryMalingering (TOMM; Tombaugh,
1996) is a visual recognition test consisting of two learn-
ing trials (Trials 1 and 2) and a retention trial.
Noncredible performance is indicated if the number of
correct trials is <45 in either Trial 2 or the retention trial.
Table 2. Characteristics of participants: control group, patients with ABI, and simulation groups (Mean±SD).
CG PABI Sim NSTBI CSTBI NSStroke CSStroke
N 40 50 192 52 48 46 46
Age (in years) 19.8 ± 1.5 42.5 ± 16.1 20.2 ± 2.2 20.8 ± 2.7 20.3 ± 2.1 20.1 ± 2.0 19.7 ± 1.7
Gender (female/male) 26/14 20/30 113/79 32/20 30/18 27/19 24/22
Education (in years) 13.2 ± 1.3 13.9 ± 3.6 13.5 ± 1.6 13.6 ± 2.0 13.5 ± 1.3 13.3 ± 1.6 13.3 ± 1.4
IQ (vocabulary skills)a b 103.3 ± 14.0 97.2 ± 7.9 96.5 ± 6.7 96.9 ± 7.7 98.0 ± 8.2 97.6 ± 9.4
aMultiple Choice Vocabulary Test (MWT-B); CG = Control group; PABI = Patients with ABI; Sim = All instructed simulation groups collapsed; NSTBI = Naïve
simulation TBI group; CSTBI = Symptom-coached simulation TBI group; NSStroke = Naïve simulation stroke group; CSStroke = Symptom-coached simulation
stroke group;
b= Not assessed in the control group.
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The Dot Counting Test (DCT; Boone et al., 2002a) is
a stand-alone validity test based on visual perception
and basic counting skills. An E-score ≥20 indicates
noncredible performance in the TBI group, whereas an
E-score ≥22 indicates noncredible performance for
stroke patients (Boone et al., 2002a). Additionally,
a revised cutoff (E-score ≥ 13.80) is employed as
reported by Roberson et al. (2013).
The b Test (Boone et al., 2002b) is a letter recognition
and discrimination task designed to detect noncredible
performance. Cutoffs for TBI patients (E-score ≥ 90)
and stroke patients (E-score ≥ 170) are defined (Boone
et al., 2002b). Additionally, a revised cutoff of E-score
≥82 is employed as suggested by McCaul et al. (2018).
Procedure
Assessment of patients with acquired brain injury
All patients with ABI were tested individually and
received no reward for participation. Written informed
consent was sought from all participants prior to the
assessment. It was pointed out to patients that all data
collected in the research project would be analyzed
anonymously and would not affect clinical assessment
and treatment. The assessment took approximately 2.5
h. The examiner was present at all times during the
assessment, and instructed patients and recorded the
answers. Patients with ABI were assessed with
a comprehensive test battery including an inventory of
descriptive and clinical information, routine measures
of cognition, a measure of intellectual functions (voca-
bulary skills), and PVTs (GET, TOMM, and DCT). The
b Test was not presented to patients with ABI.
Assessment of healthy participants
All healthy participants were tested individually in a quiet
laboratory. Written consent was obtained from all partici-
pants prior to the assessment. The assessment took
approximately 1.5 h. An instructor was present at all
times during the assessment, and was responsible for test
administration and scoring. At the beginning of the assess-
ment, before the simulation, all participants were asked to
provide descriptive information. Furthermore, intellectual
functions were assessed. The subsequent assessment pro-
cedure differed between participants of the various groups
(HC, NSTBI, CSTBI, NSStroke, and CSStroke).
Assessment of participants in the control group (HC).
Participants in the healthy control group were asked to
perform all tests to the best of their abilities. They
completed four performance validity tests (GET,
TOMM, DCT, and b Test) and received a debriefing.
Assessment of participants in the simulation group.
Participants in the simulation groups were asked to
perform the RDS test. Next, participants were randomly
presented with one of the four vignettes describing
a scenario in which someone would be motivated to
feign cognitive dysfunction. At this point, participants
in the coached conditions were also provided with
simulation instructions. Participants were then asked
to complete the following performance validity tests
(GET, TOMM, DCT, b Test) while pretending to suffer
from cognitive impairment. Finally, participants were
asked to stop simulating cognitive dysfunction, reveal
their utilized simulation strategies and were debriefed.
Simulation instructions (only presented to individuals
simulating cognitive dysfunction)
The simulation instructions (NSTBI, CSTBI, NSSTROKE,
CSSTROKE) varied with regard to the type of brain injury
(TBI or stroke) to be simulated and the level of coaching
(naïve or coached). The simulation instructions were
adapted from previous research on feigned cognitive dys-
function (Arnett, Hammeke, & Schwartz, 1995; Erdal,
2004; Rose, Hall, Szalda-Petree, & Bach, 1998). The com-
plete instructions can be found in the supplementary file
(naïve and coached simulation instructions for participants
assigned to the TBI and stroke group). Coached groups
were instructed not to be too obvious in feigning cognitive
dysfunction, in order to produce a believable performance
for someone with genuine brain injury (i.e., successful
simulation). All simulating participants were instructed to
apply their best efforts in feigning cognitive dysfunction.
To increase motivation, participants were informed that
the most successful simulation would be awarded a top-of-
the-range tablet PC. However, due to ethical reasons, the
tablet PC was eventually allocated at random to one of the
participants.
Strategy use (only presented to individuals simulating
cognitive dysfunction)
Participants were asked to reveal their strategies used
during simulation and to rate their performance. A five-
point Likert scale (ranging from 1 = strongly disagree to
5 = strongly agree) was used to assess the question of
whether they tried their best to simulate cognitive dys-
function. Participants were also asked to specify the
strategies they utilized to simulate cognitive dysfunction
(i.e., slowed down responses, inattention, memory pro-
blems, and disorganization) and were also given the
option to name other strategies used. Finally, it was
asked which of the tests the participants suspected to
be specifically designed to detect feigned cognitive
deficits.
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Compliance of ethical standards
The study was performed in accordance with the stan-
dards of the latest version of the Helsinki declaration.
Ethical approval for the assessment of patients with ABI
was obtained from the medical ethical committee of the
University of Oldenburg, Germany. Ethical permission
for the assessment of healthy individuals was obtained
from the ethical committee psychology (ECP) at the
university the authors were affiliated to.
Statistical analyses
With regard to GET test performance, the results of all
test variables were presented separately for control par-
ticipants, patients with ABI, and instructed simulators.
In addition to descriptive analysis, mean reaction time
and total number of errors were statistically compared
between groups (independent t-test with Cohen’s d as
effect size). Next, two indices were calculated for the
GET per person, i.e., the GET-ADHD index and GET-
ABI index. The algorithm for calculating the GET-
ADHD index was adopted from the original study of
Fuermaier et al. (2016), who examined the use of the
GET in differentiating genuine from feigned cognitive
dysfunction in the clinical evaluation of adult ADHD.
This index was computed by summing up the eight GET
scores, each weighted with their respective regression
coefficient to detect feigned ADHD. Furthermore, the
GET-ABI index was derived from the current data set by
summating weighted GET scores. This time, the weights
(i.e., regression coefficients) were derived from a logistic
regression analysis that predicts group membership
(genuine or feigned ABI) on the basis of the eight GET
scores as predictors. The rationale for computing this
index score was to determine which combination of
GET test variables would be best in terms of differentiat-
ing genuine from feigned cognitive dysfunction in the
present sample. The accuracy of each of the GET indices
in detecting individuals feigning ABI (collapsed group
of all simulation conditions n = 192) relative to patients
with ABI (n = 50) was explored in receiver operating
characteristics (ROC) by calculating the area under the
curves (AUC). Diagnostic accuracies (i.e., levels of sen-
sitivity and specificity) of the two GET indices were
presented and compared to other PVTs (i.e., sensitivity;
specificity toward genuine ABI could not be derived as
passing the PVTs was an inclusion criterion). In this
analysis, the cutoffs for the TOMM, DCT, b Test, and
the GET-ADHD index were taken from their respective
test manuals or publications (Boone et al., 2002a, 2002b;
Fuermaier et al., 2016; McCaul et al., 2018; Roberson
et al., 2013; Tombaugh, 1996). In addition to using the
established cutoff for the GET-ADHD index, the
proposed cutoff from the ADHD research was adapted
to achieve a specificity of 90.0% (Boone, 2007). The
same criterion (specificity of at least 90%) was applied
to determine a cutoff for the GET-ABI index.
In further analyses, the incremental validity of the
GET over the TOMM and DCT was explored in partial
ROC analyses (pROC). In these analyses, a linear regres-
sion was first computed separately for the TOMM and
DCT on the newly computed GET-ABI index. The
unstandardized residuals from this regression were
then entered into an ROC analysis to identify feigned
cognitive dysfunction relative to genuine ABI. Of note,
for this analysis patients who had failed the TOMM or
DCT, and who were therefore disregarded in the ana-
lyses described above (in order to ensure credibility of
patients with ABI), were additionally included. Because
the purpose of the pROC analysis was to determine the
diagnostic overlap between two measures (i.e., TOMM
or DCT vs. GET), patients who failed either of the tests
had to be included in order to consider both rates of
sensitivity and specificity.
Finally, simulation strategy use, and recognition of the
various PVTs as validity tests, were analyzed in descriptive
statistics by reporting absolute and relative frequencies.
Results
Utility of the GET and other established PVTs
With regard to performance on the GET, reaction times
and errors per block, mean reaction times, and the total
number of errors are shown in Table 3. Independent sample
t-tests revealed significant differences in mean reaction
times for patients with ABI compared to controls, t (88) =
3.432, p = .001, d = .71, and instructed simulators, t (240) =
2.308, p = .022, d = .36, with patients having longer mean
reaction times than both controls and instructed simulators
Table 3. Groningen Effort Test (GET) performance of control
participants, patients with ABI, and simulation groups (Mean
±SD).
Measures CG (n = 40) PABI (n = 50) Sim (n = 192)
Block 1, RT (sec) 3.8 ± 2.5 6.7 ± 5.1 5.0 ± 2.3
Block 1, Errors 1.1 ± 1.4 2.2 ± 2.6 6.6 ± 3.8
Block 2, RT (sec) 3.7 ± 3.4 5.3 ± 3.5 4.4 ± 2.2
Block 2, Errors 1.2 ± 1.3 2.2 ± 2.5 7.4 ± 4.1
Block 3, RT (sec) 2.0 ± 1.9 3.7 ± 2.7 3.5 ± 2.0
Block 3, Errors .6 ± .7 1.5 ± 2.3 6.7 ± 4.1
Block 4, RT (sec) 1.7 ± 1.3 3.6 ± 3.0 3.1 ± 1.8
Block 4, Errors .3 ± .5 1.3 ± 2.0 6.7 ± 4.3
Mean RTa 2.8 ± 2.2 4.8 ± 3.2c 4.0 ± 1.9c,d
Total Errorsb 3.1 ± 2.3 7.2 ± 7.8c 27.3 ± 14.8c,d
aMean reaction time in seconds for all four blocks combined;
bNumber of total Errors over all four blocks. CG = Control group; PABI =
Patients with ABI; Sim = All instructed simulation groups collapsed;
cSignificantly different from CG at p < .05;
dSignificantly different from PABI at p < .05.
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(Table 3). A significant difference in mean reaction times
was also found for healthy controls compared to simulators,
t (230) = 3.464, p = .001, d = .61, with controls having
shorter mean reaction times. The total number of errors
differed significantly for patients with ABI compared to
controls, t (88) = 3.214, p = .002, d = .68, for patients with
ABI compared to simulators, t (240) = −9.29, p < .001, d =
1.47, and for controls compared to simulators, t (230) =
10.313, p < .001, d = 1.79, with patients making more
mistakes than controls, but fewer than instructed
simulators.
The ability of the GET to detect simulated cogni-
tive dysfunction (n = 192) relative to genuine pathol-
ogy (n = 50) was analyzed by the use of two GET
indices. First, the GET-ADHD index was computed
by summing up the eight GET scores, each weighted
with the regression coefficients as adopted from the
original study of Fuermaier et al. (2016). Despite
being developed for an ADHD sample, the GET-
ADHD index also performed well in the present
study with regard to the identification of feigned
cognitive dysfunction after ABI, AUC = .914, SE =
.021, CI = .872; .956, and p < .001.
Second, for the calculation of the GET-ABI index, the
weights (i.e., regression coefficients) were derived from
a logistic regression analysis that predicts group mem-
bership (genuine or feigned ABI) on the basis of the
eight GET scores as predictors. A significant model was
found for the identification of feigned ABI (collapsed
group of all simulation conditions, n = 192) relative to
patients with ABI (n = 50), with χ2 (8, n = 242) = 138.11,
p < .001, explaining 43.5% of the variance (Cox &
Snell2). The prediction equation was as follows: GET-
ABI index = −.381 Block 1 RT + .238 Block 1 Errors –
.005 Block 2 RT + .048 Block 2 Errors + .821 Block 3 RT +
.41 Block 3 Errors – .953 Block 4 RT + .356 Block 4 Errors.
The accuracy of the newly developed GET-ABI index in
detecting individuals feigning ABI (collapsed group of
all simulation conditions, n = 192) relative to patients
with ABI (n = 50) was explored in an ROC analysis. In
this analysis, the GET-ABI index’s ability to identify
simulated cognitive dysfunction was excellent: AUC =
.949, SE = .014, CI = .922; .976, and p < .001. The flow of
participants and diagnostic accuracy of the GET-ABI
index is depicted in Figure 1; a graphical presentation of
the ROC curve is shown in Figure 2.
Figure 1. STARD diagram reporting flow of participants and diagnostic accuracy of GET-ABI index (cutoff .791).
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The test performance of participants on all PVTs,
including performance on the TOMM, DCT, b Test
and GET, is presented in Table 4. Table 5 presents the
ability of validity tests to distinguish feigned from gen-
uine cognitive dysfunction, along with their cutoffs and
respective levels of sensitivity, specificity, and AUC. For
the GET-ADHD index, the proposed cutoff from
ADHD research of ≥ −.25 results in 92.2% sensitivity
but only 64.0% specificity. Therefore, an adapted cutoff
was determined for the GET-ADHD index to achieve
specificity of 90.0% (Boone, 2007), which resulted in
a sensitivity level of 82.3%. With regard to the GET-
ABI index, achieving specificity of at least 90% resulted
in a suitable cutoff of .791 at a sensitivity level of 88.5%.
The TOMM’s ability to identify feigned cognitive dys-
function was excellent, with a sensitivity of 98.4% at the
established cutoff of ≤45 (Tombaugh, 1996). The b Test
performed fairly with a sensitivity of 70.3%, at the cut-
offs ≥90 and ≥170 for TBI and stroke, respectively
(Boone et al., 2002b), but performed well with
a sensitivity of 86.5% at the cutoff ≥82 (Roberson
et al., 2013). The DCT performed rather poorly with
a sensitivity of only 39.1% based on the cutoffs suggested
in the test manual (i.e., E-score ≥ 20 for TBI, E-score ≥
22 for stroke), but performed well with a sensitivity of
80.7% at the cutoff ≥ 13.80 (McCaul et al., 2018).
Incremental validity of the GET over already
established PVTs
The incremental validity of the GET over the TOMM and
DCT was explored in partial ROC analyses (pROC; see
Figure 3). In this analysis, patients who failed either of the
tests were included, resulting in 192 simulators and 55
patients with ABI with genuine cognitive dysfunctions.
Regressing the DCT on the GET-ABI index revealed
a significant model: F(1, 244) = 79.05, p < .001, with
24.5% explained variance. pROC analysis on the GET-
ABI index to identify feigned cognitive dysfunction inde-
pendently from the contribution of the DCT indicated
good diagnostic accuracy: pAUC = .849, SE = .025, CI =
.800; .899, and p < .001. Furthermore, regressing the
TOMM on the GET-ABI scores also revealed a significant
model, F(2, 236) = 157.93, p < .001, with explained variance
reaching 57.2%. The pROC demonstrated that the GET-
ABI index did not add significant diagnostic accuracy of
Figure 2. ROC curve depicting diagnostic accuracy of the GET-ABI
index andGET-ADHD index in identifying feigned cognitive dysfunc-
tion (n = 192) relative to genuine cognitive dysfunction (n = 50).
Table 4. Performance validity tests of control participants,
patients with ABI, and simulation groups (Mean ± SD).
CG (n = 40) PABI (n = 50) Sim (n = 192)
GET-ABI index −.7 ± .5 −1.3 ± 1.9 5.0 ± 4.0
GET-ADHD index −1.7 ± 1.7 −1.1 ± 3.1 6.7 ± 5.3
b Test E-score 40.2 ± 11.1 a 655.0 ± 1075.0
DCT E-score 8.6 ± 2.0 10.5 ± 3.9 20.4 ± 8.9
TOMM T2 50.0 ± .0 49.9 ± .5 29.5 ± 8.2
TOMM R 50.0 ± .2 49.8 ± .7 28.6 ± 8.3
CG = Control group; PABI = Patients with ABI; Sim = All instructed simulation
groups collapsed; GET = Groningen Effort Test; DCT = Dot Counting Test;
TOMM T2 = Test Of Memory Malingering Trial 2; TOMM R = Test Of
Memory Malingering Retention Trial;
a= Not assessed in patients with ABI.
Table 5. Diagnostic accuracy of various validity tests in distin-
guishing feigned (n = 192) from genuine (n = 50) cognitive
dysfunction, as indicated by levels of sensitivity, specificity, and
area under the curve.









TBI ≥ 20, Stroke ≥ 22d 39.1 h
≥13.80e 80.7 h
b Test (E-Score)
TBI ≥ 90, Stroke ≥ 170f 70.3 i
≥82g 86.5 i
AUC = Area under the curve; GET = Groningen Effort Test; DCT = Dot
Counting Test; TOMM = Test Of Memory Malingering;
a= cutoff adopted from ADHD research (Fuermaier et al., 2016);
b= cutoff derived from this study in order to maximize specificity to at least
90%;
c= cutoff adopted from test manual suggesting noncredible performance:
trial 2 or retention trial ≤45 (Tombaugh, 1996);
d= cutoff adopted from test manual suggesting noncredible performance:
TBI ≥ 20, Stroke ≥ 22 (Boone et al., 2002a);
ecutoff adopted from McCaul et al. (2018);
f= cutoff adopted from test manual suggesting noncredible performance:
TBI ≥ 90, Stroke ≥ 170 (Boone et al., 2002b);
gcutoff adopted from Roberson et al. (2013);
h= not possible to derive as passing was an inclusion criteria for entering this
study;
i= Not assessed in patients with ABI.
292 A. B. M. FUERMAIER ET AL.
feigned cognitive dysfunction to the TOMM: pAUC = .470,
SE = .043, CI = .387; .553, and p < .526.
Simulation strategy use and face validity of PVTs
The majority of participants reported that they tried to
feign cognitive dysfunction in the domain of executive
functions (n = 135, 70.3%), attention (n = 102, 53.1%),
speed of responses (n = 40, 20.8%) and memory (n = 34,
17.7%).With regard to these four simulation strategies, the
four PVTs tests used in this study did not vary considerably
in terms of identifying simulators across different cognitive
domains (Table 6). The TOMM performed best, recogniz-
ing between 91.2% and 98.5% of participants applying
a specific simulation strategy. TheGET recognized between
82.4% and 89.2%of participants employing a specific simu-
lation strategy, while the b Test recognized between 55.9%
and 66.7%. The DCT, showing the lowest diagnostic accu-
racy, identified only between 26.5% and 33.3% of the
simulators that employed specific strategies. Instructed
simulators (n = 192) did not vary greatly in terms of
which validity test they recognized as a validity test. If test
takers are told that there are PVTs in the battery, they are
most likely to pick the DCT as a validity test (n = 76;
39.6%), followed by the TOMM (n = 69; 35.9%), GET
(n = 55; 28.6%), and b Test (n = 51; 26.6%).
Discussion
Neuropsychological assessment using routine measures
of cognition revealed that a sizable proportion of
patients with ABI had impairments in attention (15–
35%), visuoconstructive abilities (19–29%), and word
fluency (33–48%). While cognitive impairments were
observed in several aspects of cognition, these impair-
ments did not appear to affect GET performance detri-
mentally. In fact, an inspection of test performance
showed that the GET was relatively easy to perform
for both patients with ABI and healthy controls, as
demonstrated by low error rates in both groups (on
average about 3–7 errors out of 94 items).
Nevertheless, inferential statistics of group differences
on GET performance reached significance levels, indi-
cating effects of medium size. More specifically, patients
with ABI had significantly longer response times than
controls, while making significantly more mistakes.
Instructed simulators on the other hand had signifi-
cantly shorter response times (small effect) but com-
mitted significantly more errors (large effect) than
patients with ABI. This might indicate a trade-off of
speed for accuracy for instructed simulators.
With regard to the detection of feigned cognitive dys-
function, the TOMM was best in detecting feigning (sen-
sitivity = 98.4%), closely followed by the GET which also
showed excellent overall classification accuracy (AUC =
.949; sensitivity of 88.5% at a specificity of 90%). The
b Test and DCT showed an inferior performance to the
GET and TOMM, with sensitivity levels of 70.3% and
39.1%, respectively, based on cutoffs as derived from the
test manuals. Higher rates of sensitivity (80.7% for the
DCT and 86.5% for the b Test) were reached based on the
more recently suggested cutoffs. However, it can be
argued that the traditional, lenient cutoffs may be more
applicable for this sample of patients with brain injury,
given the more impaired status of this sample relative to
the typical heterogeneous neuropsychology clinic popu-
lation. This is supported by the high failure rate of the
DCT in the patient sample based on the revised cutoff
(26%) compared to the traditional cutoff (7%). While the
GET was shown to have good incremental validity over
the DCT (pAUC = .849), no incremental validity was
achieved over the TOMM (pAUC = .470). It must be
noted that the classification accuracy of the GET-ABI
index may be slightly overestimated, as the derivation of
Figure 3. ROC curve depicting diagnostic accuracy of the GET-
ABI index in identifying feigned cognitive dysfunction (n = 192)
relative to genuine cognitive dysfunction (n = 55) after partial-
ing out DCT or TOMM.
Table 6. Diagnostic accuracy of various validity tests to detect
feigning (N(%)) per simulation strategy used: speed, inattention,
memory, executive functions.
Speed Inattention Memory Executive functions
(n = 40) (n = 102) (n = 34) (n = 135)
GET-ABI index 34 (85.0) 91 (89.2) 28 (82.4) 117 (86.7)
TOMM 39 (97.5) 100 (98) 31 (91.2) 133 (98.5)
DCT 12 (30) 29 (28.4) 9 (26.5) 45 (33.3)
b Test 25 (62.5) 68 (66.7) 19 (55.9) 86 (63.7)
GET = Groningen Effort Test; DCT = Dot Counting Test; TOMM = Test Of
Memory Malingering.
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the index and its evaluation was performed on the same
sample. Nevertheless, the previously established GET-
ADHD index also performed well in this context. Of
note, the results are based on a study using a simulation
design, which may over-estimate levels of sensitivity, as
simulation designs are known to be limited in regard to
the representation of real-life feigning. Given the results
still hold in studies using known-groups methodology, it
may be concluded that the GET is a useful instrument in
distinguishing genuine from feigned cognitive dysfunc-
tion after ABI, with comparable classification rates to the
TOMM, and comparable to superior accuracy (depend-
ing on the cutoff used) compared to the b Test and the
DCT. It can further be concluded that the GET has
a broad scope of application, and may, given further
clinical validation, be a useful tool for the assessment of
the performance validity of patients, not only in
a psychiatric (Fuermaier et al., 2016) but also
a neurological setting. Optimal application of the GET
in various settings requires further validation in clinical
practice using different research methodology, as well as
the development of disorder-specific algorithms and cut-
offs. This is suggested for the majority of already existing
PVTs, and is also indicated for the GET since the present
data in comparison to previous work using the GET
(Fuermaier et al., 2016) show that the diagnostic accuracy
of a single cutoff on a predefined variable varies per
diagnostic group.
Since the validity of PVTs may be compromised
when used repeatedly in the reassessment of a client,
it is advantageous to have access to alternative mea-
sures with high diagnostic value (Carone, Iverson, &
Bush, 2010). In this context, the GET can be
a valuable tool. Furthermore, considering that about
half of the instructed simulators of the present study
had been coached to simulate cognitive dysfunctions,
it can be assumed that the GET is robust against
well-prepared individuals trying to feign cognitive
dysfunction. The GET is also unlikely to be recog-
nized by most participants as an validity measure
due to its characteristics that resemble standard mea-
sures of attention. In the present study, fewer than
a third of the simulators recognized the GET as
a validity test, even though they were all aware that
at least one of the tests administered was designed to
assess performance validity. Moreover, as another
advantage, the GET appears not only to be sensitive
toward feigned attention disorders, but also toward
other simulation strategies, such as executive dys-
function and memory impairment. Similar results
were observed for other PVTs applied, showing that
successful identification of feigning was largely inde-
pendent of the simulation strategy used.
Limitations and future directions
The present study has to be seen in the context of several
limitations. Simulation designs, by nature, can be criti-
cized for limited external validity (Rogers & Cruise,
1998), as they may not present the simulating behavior
of individuals in clinical practice. Different methodolo-
gical approaches, such as known-groups comparisons
(Rogers, Harrell, & Liff, 1993), should thus be used in
future studies to complement the present findings. To
ensure quality of the present data and increase the
external validity of this study, strict exclusion criteria
were applied in the selection of participants. Healthy
controls and patients with ABI had to pass multiple
established validity tests in order to ensure credibility
of their test performances. Furthermore, instructed
simulators were excluded if they scored below the cutoff
of the RDS, indicating noncredible performance prior to
simulation. It was also verified that instructed simula-
tors had read and understood the instructions before
performing the PVTs. Moreover, instructed simulators
were asked after completion of the assessment whether
they had applied their best effort in feigning cognitive
dysfunction, and participants with coached simulation
conditions were warned not to overdo their simulation
and not to make their problems too obvious. Finally,
participants were further motivated by the chance of
winning a tablet PC, because past research in the field
has shown that monetary incentives influence perfor-
mance on clinical instruments (Binder & Rohling, 1996;
Binder & Willis, 1991). However, more solid recom-
mendations for clinical use can be given if it is known
how the GET performs in studies using known-groups
methodology.
Furthermore, it must be noted that standard instruc-
tions of neuropsychological testing were altered by
informing test takers that at least one test was designed
to assess performance validity, which may have influ-
enced the participants’ test performance. For example,
by telling test takers that there are PVTs in the battery,
they may pick a specific test as a PVT, and then reign in
their feigning on this measure. Assuming this instruc-
tion affected test performance, it can be argued that it
may have resulted in a more conservative estimation of
classification rates. One may also argue that the com-
parison of classification rates across tests was still largely
unaffected, given the rather similar rates with which the
tests were recognized as a PVT.
Another caveat was that healthy individuals and
instructed simulators were students and may therefore
not be representative of the patient group (e.g., with
regard to age, gender, and education). However, we do
not regard this as a substantial problem for the present
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study, as in general validity tests have been found to be
largely independent of variables such as age and educa-
tion, because only at extremes of these variables may
distorted test results occur (Green & Flaro, 2003;
Heilbronner et al., 2009). This may be one of the reasons
why most established validity tests do not have age- or
education-based norms but provide normative data
based on diagnostic groups.
Furthermore, the composition of the patient sample
and their disease severity may not be fully applicable to
this context. As this study made use of a mixed ABI
patient group consisting of patients with stroke or TBI,
future research should aim for larger sample sizes to
adequately differentiate patients and simulators accord-
ing to the etiology of their condition. Furthermore, past
research in this field has mainly studied patients with
mild cases of ABI, which corresponds to the finding that
individuals feigning cognitive deficits aiming for
a financial payoff in personal injury litigation cases
usually suffer from mild cognitive impairments
(Reynolds & Horton, 2012). By including cases with
more severe ABI in the present study, we showed that
the GET can even be performed by more severely cog-
nitively impaired patients, which may lead to an under-
estimation of the differences between patients with
mild/moderate ABI and instructed stimulators.
Finally, coaching instructions may not be comparable
to how individuals would prepare themselves before
attempting to simulate cognitive dysfunction after ABI in
real life. Past research has shown that people attempting to
feign cognitive dysfunction tend to exaggerate deficits
because of an underestimation of the functions retained
and an overestimation of the test difficulty (Iverson &
Franzen, 1998; Mittenberg, Azrin, Millsaps, &
Heilbronner, 1993). Other research has shown that coach-
ing participants with regard to simulation can attenuate
this effect (Rose et al., 1998). Even though Suhr and
Gunstad (2000) have demonstrated that cautionary
remarks in the coaching instructions also lead to better
malingering performances, the depth and detail of simula-
tion strategies provided in the present context may not be
representative of the preparation of an individual actually
trying to feign cognitive dysfunction in real life.
Conclusion
The present study employed a simulation design to
determine the utility of the GET in differentiating cred-
ible from noncredible cognitive dysfunction after ABI,
i.e., stroke or TBI. A disorder-specific algorithm and
cutoffs were derived which showed the GET to have
excellent overall classification accuracy, with diagnostic
accuracy levels close to the TOMM, and superior to the
b Test and DCT. Furthermore, high diagnostic accuracy
was stable and established independently from simula-
tion strategies applied by simulators. Finally, face validity
of the GET as a validity measure may be low, with only
a minority of participants recognizing the GET as
a validity measure. In conclusion, results of this simula-
tion design support the GET’s utility, in particular when
applying disorder-specific algorithms, and thus suggests
a broad field of application including patients with neu-
rological conditions. The GET may complement neurop-
sychological assessments of patients with ABI, but needs
further validation in studies using different research
methodology, such as known-groups designs, before
more solid clinical recommendations can be given.
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